Review of Clinical Outcome Assessments in Pediatric Attention-Deficit/Hyperactivity Disorder

References

• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). Arlington, VA: American Psychiatric Publishing; 2013.
   Google Scholar
• Centers for Disease Control and Prevention. Data and statistics about ADHD. Available from: https://www.cdc.gov/ncbddd/adhd/data.html. Accessed 95, 2019.
   Google Scholar
• Hamed AM, Kauer AJ, Stevens HE. Why the diagnosis of attention deficit hyperactivity disorder matters. Front Psychiatry. 2015;6:168. doi:10.3389/fpsyt.2015.0016826635643
   PubMed Web of Science ®Google Scholar
• Wolraich M, Brown L, Brown RT, et al. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2011;128(5):1007–1022.22003063
   PubMed Web of Science ®Google Scholar
• Feldman ME, Charach A, Belanger SA. ADHD in children and youth: part 2-treatment. Paediatr Child Health. 2018;23(7):462–472. doi:10.1093/pch/pxy11330681665
   PubMed Web of Science ®Google Scholar
• Coghill D, Seth S. Effective management of attention-deficit/hyperactivity disorder (ADHD) through structured re-assessment: the Dundee ADHD Clinical Care Pathway. Child Adolesc Psychiatry Ment Health. 2015;9:52. doi:10.1186/s13034-015-0083-226587055
   PubMed Web of Science ®Google Scholar
• Woods D, Wolraich M, Pierce K, Dimarco L, Muller N, Sachdeva R. Considerations and evidence for an ADHD outcome measure. Acad Pediatr. 2014;14(5):54–60. doi:10.1016/j.acap.2014.06.01124369869
   PubMed Web of Science ®Google Scholar
• Epstein JN, Loren REA. Changes in the definition of ADHD in DSM-5: subtle but important. Neuropsychiatry. 2013;3(5):455–458. doi:10.2217/npy.13.5924644516
   PubMedGoogle Scholar
• Epstein JN, Weiss MD. Assessing treatment outcomes in attention-deficit/hyperactivity disorder: a narrative review. Prim Care Companion J Clin Psychiatry. 2012;14(6):1–20.
   Google Scholar
• U.S. Food and Drug Administration. Clinical outcome assessments (COA): frequently asked questions. Available from: https://www.fda.gov/about-fda/clinical-outcome-assessments-coa-frequently-asked-questions#COADefinition. Accessed 95, 2019.
   Google Scholar
• Walton MK, Powers JH, Hobart J, et al. Clinical outcome assessments: conceptual foundation-report of the ISPOR clinical outcomes assessment-emerging good practices for outcomes research task force. Value Health. 2015;18(6):741–752. doi:10.1016/j.jval.2015.08.00626409600
   PubMed Web of Science ®Google Scholar
• U.S. Food and Drug Administration. Guidance for industry: patient-reported outcome measures–use in medical product development to support labeling claims. Available from: https://www.fda.gov/media/77832/download. Accessed 916, 2019.
   Google Scholar
• Bussing R, Koro-Ljungberg M, Noguchi K, Mason D, Mayerson G, Garvan CW. Willingness to use ADHD treatments: A mixed methods study of perceptions by adolescents, parents, health professionals and teachers. Soc Sci Med. 2012;74(1):92–100.22133584
   PubMed Web of Science ®Google Scholar
• Chavez L, Mir K, Canino G. Starting from Scratch: The Development of the Adolescent Quality of Life-Mental Health Scale (AQOL-MHS). Cult Med Psychiatry. 2012;36(3):465–479.22528055
   PubMed Web of Science ®Google Scholar
• Dewey D, Volkovinskaia A. Health-related quality of life and peer relationships in adolescents with developmental coordination disorder and attention-deficit-hyperactivity disorder. Dev Med Child Neurol. 2018;60(7):711–717.29611868
   PubMed Web of Science ®Google Scholar
• Hareendran A, Setyawan J, Pokrzywinski R, Steenrod A, Madhoo M, Erder MH. Evaluating functional outcomes in adolescents with attention-deficit/hyperactivity disorder: development and initial testing of a self-report instrument. Health Qual Life Outcomes. 2015;13:133.26297205
   PubMed Web of Science ®Google Scholar
• Laugesen B, Groenkjaer M. Parenting experiences of living with a child with attention deficit hyperactivity disorder: a systematic review of qualitative evidence. JBI Database Syst Rev Implement Reports. 2015;13(11):169–234.
   Google Scholar
• Lloyd A, Hodgkins P, Sasane R, et al. Estimation of utilities in attention-deficit hyperactivity disorder for economic evaluations. Patient. 2011;4(4):247–257.21995830
   PubMedGoogle Scholar
• Mofokeng M, van der Wath AE. Challenges experienced by parents living with a child with attention deficit hyperactivity disorder. J Child Adolesc Ment Health. 2017;29(2):137–145.28974169
   PubMed Web of Science ®Google Scholar
• Barkley RA, Murphy KR. Current symptoms self-report scale In: Attention-Deficit Hyperactivity Disorder: A Clinical Workbook. 2nd ed. Guilford Press; 1998.
   Google Scholar
• DuPaul GJ, Power TJ, Anastopoulos AD, Reid R. ADHD Rating Scale-5 for Children and Adolescents: Checklists, Norms, and Clinical Interpretation. New York, NY: Guilford Press; 2016.
   Google Scholar
• Adler L, Kessler R, Spencer T. Adult ADHD Self-Report Scale-V1. 1 (ASRS-V1. 1) Symptom Checklist. New York, NY: World Health Organization; 2003.
   Google Scholar
• Swanson J, Schuck S, Porter M, et al. Categorical and dimensional definitions and evaluations of symptoms of ADHD: history of the SNAP and the SWAN rating scales. Int J Educ Psychol Assess. 2012;10(1):51–70.26504617
   PubMedGoogle Scholar
• Haack LM, Gerdes AC, Lawton KE, Schneider BW. Understanding and measuring functional impairment in diverse children with ADHD: development of the ADHD-FX scale with an at-risk, community sample. J Atten Disord. 2016;20(6):487–500. doi:10.1177/108705471452779124695438
   PubMed Web of Science ®Google Scholar
• Haack LM, Gonring K, Harris M, Gerdes A, Pfiffner L. Assessing impairment in childhood ADHD: validation of the parent and teacher ADHD-FX rating scale in a dual-site clinical sample. J Atten Disord. 2019;23(6):541–552. doi:10.1177/108705471665936027431931
   PubMed Web of Science ®Google Scholar
• Landgraf JM, Rich M, Rappaport L. Measuring quality of life in children with attention-deficit/hyperactivity disorder and their families: development and evaluation of a new tool. Arch Pediatr Adolesc Med. 2002;156(4):384–391. doi:10.1001/archpedi.156.4.38411929374
   PubMedGoogle Scholar
• Breuer D, Gortz-Dorten A, Rothenberger A, Dopfner M. Assessment of daily profiles of ADHD and ODD symptoms, and symptomatology related to ADHD medication, by parent and teacher ratings. Eur Child Adolesc Psychiatry. 2011;20(Suppl 2):S289–96. doi:10.1007/s00787-011-0206-021901413
   PubMedGoogle Scholar
• DefiniPoint. Impairment rating scale. Available from: https://www.attentionpoint.com/x_upload/media/images/definipoint_instrument_overview_130423.pdf. Accessed 215, 2019.
   Google Scholar
• Swanson JM, Lerner M, Wigal T, et al. The use of a laboratory school protocol to evaluate concepts about efficacy and side effects of new formulations of stimulant medications. J Atten Disord. 2002;6(Suppl 1):S73–88. doi:10.1177/070674370200601S1012685522
   PubMedGoogle Scholar
• Wigal SB, Gupta S, Guinta D, Swanson JM. Reliability and validity of the SKAMP rating scale in a laboratory school setting. Psychopharmacol Bull. 1998;34(1):47–53.9564198
   PubMedGoogle Scholar
• Wigal SB, Wigal TL. The laboratory school protocol: its origin, use, and new applications. J Atten Disord. 2006;10(1):92–111. doi:10.1177/108705470528604916840597
   PubMedGoogle Scholar
• Wigal SB. Laboratory school protocol mini-review: use of direct observational and objective measures to assess ADHD treatment response across the lifespan. Front Psychol. 2019;10:1796. doi:10.3389/fpsyg.2019.0179631496966
   PubMed Web of Science ®Google Scholar
• Swanson JM, Alger D, Fineberg E, et al. UCI laboratory school protocol for PK/PD studies. In: Greenhill L, Osman B (eds), Ritalin: Theory and Practice, 2nd Edition.Larchmont, NY: Mary Ann Liebert: 1999;405–460.
   Google Scholar
• Swanson J. The SNAP-IV teacher and parent rating scale In: Fine A, Kotkin R, eds. Therapist’s Guide to Learning and Attention Disorders. Elsevier; 2003:487–500.
   Google Scholar
• Wolraich ML, Feurer ID, Hannah JN, Baumgaertel A, Pinnock TY. Obtaining systematic teacher reports of disruptive behavior disorders utilizing DSM-IV. J Abnorm Child Psychol. 1998;26(2):141–152. doi:10.1023/A:10226739064019634136
   PubMed Web of Science ®Google Scholar
• Futures B. Vanderbilt ADHD diagnostic teacher rating scale. Available from: https://www.brightfutures.org/mentalhealth/pdf/professionals/bridges/adhd.pdf. Accessed 916, 2019.
   Google Scholar
• Canadian ADHD Resource Alliance. Weiss functional impairment rating scale - Parent Report (WFIRS-P). Available from: https://www.caddra.ca/pdfs/caddraGuidelines2011_Toolkit.pdf. Accessed 916, 2019.
   Google Scholar
• Thompson T, Lloyd A, Joseph A, Weiss M. The Weiss functional impairment rating scale-parent form for assessing ADHD: evaluating diagnostic accuracy and determining optimal thresholds using ROC analysis. Qual Life Res. 2017;26(7):1879–1885. doi:10.1007/s11136-017-1514-828220338
   PubMed Web of Science ®Google Scholar
• Conners CK, Pitkanen J, Rzepa SR. Conners 3rd edition (Conners 3; Conners 2008) In: Kreutzer JS, DeLuca J, Caplan B, editors. Encyclopedia of Clinical Neuropsychology. New York, NY: Springer; 2011:675–678.
   Google Scholar
• Bright Futures. Vanderbilt ADHD Diagnostic Teacher Rating Scale. Available from: https://www.brightfutures.org/mentalhealth/pdf/professionals/bridges/adhd.pdf. Accessed 9 16, 2019.
   Google Scholar
• Canadian ADHD Resource Alliance. Weiss Functional Impairment Rating Scale - Parent Report (WFIRS-P). Available from: https://www.caddra.ca/pdfs/caddraGuidelines2011_Toolkit.pdf. Accessed 9 16, 2019.
   Google Scholar
• HealthAct CHQ. AIM-C: ADHD impact module - childTM. Available from: https://www.healthactchq.com/survey/aim-c. Accessed 916, 2019.
   Google Scholar
• Daughton JM, Kratochvil CJ. Review of ADHD pharmacotherapies: advantages, disadvantages, and clinical pearls. J Am Acad Child Adolesc Psychiatry. 2009;48(3):240–248. doi:10.1097/CHI.0b013e318197748f19242289
   PubMed Web of Science ®Google Scholar